Breath Therapeutics is a biopharmaceutical company that develops inhalation therapies for severe respiratory diseases.
Business Model:
Revenue: $3M
Employees: 51-200
Breath Therapeutics was acquired by
Zambon Pharma.
The acquisition happend on 2019-07-25.
Details of the transaction were not public
Address: Aldringenstrabe 4
City: Munich
State: bavaria
Zip: 80639
Country: DE
Breath Therapeutics is a biopharmaceutical company that develops inhalation therapies for severe respiratory diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2017 | Series A | $48.6M |
GIMV Sofinnova Partners |
3/2017 | Series A | 3 | $45.9M |
Gilde Healthcare Gimv Sofinnova Partners Gilde Healthcare Gimv Sofinnova Partners |
3/2017 | Series A | 3 | $45.9M |
Gilde Healthcare Gimv Sofinnova Partners Gilde Healthcare Gimv Sofinnova Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|